宝贝儿好深夹的太紧了

宝贝儿好深夹的太紧了ABNewswire is a paid press release distribution service with a difference because it helps you gain greater visibility through its unique and advanced press release writing and distribution processes.

Thursday, June 25, 2020

Industrial Wireless Remote Control Market - Detailed Historical Analysis From 2013-2018 And Forecasts From 2019-2028: Radiant Insights, Inc

Industrial Wireless Remote Control Market - Detailed Historical Analysis From 2013-2018 And Forecasts From 2019-2028: Radiant Insights, Inc
"Market Research and Consulting Company"
2013-2028 Report on Global Industrial Wireless Remote Control Market by Player, Region, Type, Application and Sales Channel

宝贝儿好深夹的太紧了The global Industrial Wireless Remote Control market was valued at $XX million in 2018, and Radiant Insights analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for Industrial Wireless Remote Control from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Industrial Wireless Remote Control market.

Request a Free Sample Copy of Industrial Wireless Remote Control Market Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-industrial-wireless-remote-control-market/request-sample

宝贝儿好深夹的太紧了

? HBC
? Hetronic Group
? Laird(Cattron Group)
? OMNEX(Eaton)
? Ikusi
? Tele Radio
? NBB
? Scanreco
? Autec
? Green Electric
? Akerstroms
? Yuding
? Shize
? Remote Control Technology
? 3-ELITE PTE
? ITOWA
? JAY Electronique
? Wicontek
? Lodar
? Shanghai Techwell Auto-control Technology
? Yijiu

Market split by Type, can be divided into:

? Pushbutton Type
? Joystick Type

Market split by Application, can be divided into:

? Industry & Logistics
? Construction Crane
? Mobile Hydraulics
? Forestry
? Mining
? Others

Market split by Sales Channel, can be divided into:

? Direct Channel
? Distribution Channel

Market segment by Region/Country including:

? North America (United States, Canada and Mexico)
? Europe (Germany, UK, France, Italy, Russia and Spain etc.)
? Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
? South America Brazil, Argentina, Colombia and Chile etc.)
? Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

The report “Industrial Wireless Remote Control Market” is available now at https://www.radiantinsights.com/research/2013-2028-report-on-global-industrial-wireless-remote-control-market

Table of Contents

Chapter 1 Industrial Wireless Remote Control Market Overview
1.1 Industrial Wireless Remote Control Definition
1.2 Global Industrial Wireless Remote Control Market Size Status and Outlook (2013-2028)
1.3 Global Industrial Wireless Remote Control Market Size Comparison by Region (2013-2028)
1.4 Global Industrial Wireless Remote Control Market Size Comparison by Type (2013-2028)
1.5 Global Industrial Wireless Remote Control Market Size Comparison by Application (2013-2028)
1.6 Global Industrial Wireless Remote Control Market Size Comparison by Sales Channel (2013-2028)
1.7 Industrial Wireless Remote Control Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)

Chapter 2 Industrial Wireless Remote Control Market Segment Analysis by Player
2.1 Global Industrial Wireless Remote Control Sales and Market Share by Player (2016-2018)
2.2 Global Industrial Wireless Remote Control Revenue and Market Share by Player (2016-2018)
2.3 Global Industrial Wireless Remote Control Average Price by Player (2016-2018)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player

Chapter 3 Industrial Wireless Remote Control Market Segment Analysis by Type
3.1 Global Industrial Wireless Remote Control Market by Type
3.1.1 Pushbutton Type
3.1.2 Joystick Type
3.2 Global Industrial Wireless Remote Control Sales and Market Share by Type (2013-2018)
3.3 Global Industrial Wireless Remote Control Revenue and Market Share by Type (2013-2018)
3.4 Global Industrial Wireless Remote Control Average Price by Type (2013-2018)
3.5 Leading Players of Industrial Wireless Remote Control by Type in 2018
3.6 Conclusion of Segment by Type

Chapter 4 Industrial Wireless Remote Control Market Segment Analysis by Application
4.1 Global Industrial Wireless Remote Control Market by Application
4.1.1 Industry & Logistics
4.1.2 Construction Crane
4.1.3 Mobile Hydraulics
4.1.4 Forestry
4.1.5 Mining
4.2 Global Industrial Wireless Remote Control Sales and Market Share by Application (2013-2018)
4.3 Leading Consumers of Industrial Wireless Remote Control by Application in 2018
4.4 Conclusion of Segment by Application

Read more research reports of this category by Radiant Insights:

? Pump Market - https://www.radiantinsights.com/research/pump-market

? Automated Guided Vehicle Market - https://www.radiantinsights.com/research/2013-2028-report-on-global-automated-guided-vehicle-market

? Water Filter Jug Market - https://www.radiantinsights.com/research/2013-2028-report-on-global-water-filter-jug-market

About Radiant Insights, Inc
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist - USA
Email:Send Email
Phone: (415) 349-0054, Toll Free: 1-888-928-9744
Address:201 Spear Street 1100, Suite 3036
City: San Francisco
State: CA
Country: United States
Website: www.radiantinsights.com/research/2013-2028-report-on-global-industrial-wireless-remote-control-market

Lexaria Bioscience Brings Next-Generation Technology To Mainstream With Its DehydraTECH? Platform 

As the ongoing COVID-19 pandemic continues to remind us, infectious diseases are an unavoidable fact of life. Although antibiotics and antivirals have been developed for many conditions, the medical industry continues to search for newer and more effective treatments to offer patients. Lexaria Bioscience (OTCMKTS: LXRP) is answering that call with cost-effective technology that is already being licensed by billion-dollar companies across a broad range of sectors.

Lexaria Bioscience’s drug delivery platform, DehydraTECH?, is positioned as a potentially revolutionary drug delivery technology. Its use extends seamlessly through multiple areas of the pharmaceutical sector by taking existing orally-administered therapies and improving the way they are detected and absorbed by the body. 

Because the adaptable platform is focused on improving drugs that are already approved, Lexaria can integrate its next-gen dehydration technology without facing lengthy and cost-prohibitive FDA oversight. Simultaneously, the broad applications of the technology can increase drug effectiveness at lower dosages, attracting interest from potential licensees in the nicotine, pharmaceutical-grade CBD, and disease treatment sectors.

Lexaria believes their DehydraTECH? can change the future for essential drugs where time to relief is a primary concern to the user. It would also offer a substantial marketing benefit to the Lexaria licensee, making it a win-win proposition.

Lexaria Bioscience Could Augment the Medical Industry’s Most Important Treatments

Drug and treatment administration are critical components for drug companies. It can mean the difference in billions of drug marketing revenue and is a determining factor in measuring efficacy and speed of relief standards. The most common forms of antibiotic or antiviral drugs are pills that are orally administered. While this may be the most prevalent method of drug introduction, many treatments ultimately suffer from low levels of oral bioavailability due to poor water-solubility. This critical limitation often results in a tiny fraction of the active ingredient being absorbed by the patient and limiting both therapeutic effectiveness and patient response to the drug. Lexaria is addressing this issue head-on.

Lexaria’s DehydraTECH? platform may be a disruptive force for multiple sectors, especially to companies that rely on orally-administered drugs and treatments for their products. The primary benefit is that the technology could substantially improve onset and bioavailability for hundreds of existing drugs currently saddled by oral bioavailability limitations. The diverse market opportunities for DehydraTECH? extend to use with antivirals, oral nicotine, NSAIDs such as Ibuprofen and Aspirin, cannabinoids, fat-soluble vitamins, PDE5 inhibitors such as Viagra, and hormones such as estrogen and testosterone.

Moreover, the applications of the technology are far-reaching. The platform can incorporate near-unlimited combinations of active-ingredients to particular binding agents, helping to create substantial revenue-generating opportunities beyond pharmaceuticals. 

DehydraTECH? Technology A Game-Changer For Oral Drug Delivery

DehydraTECH? works by combining the drug or Active Pharmaceutical Ingredient (“API”) with a fatty acid oil, such as a long-chain fatty acid. This mixture is applied to food or carrier particles such as sorbitol or gum arabic, which then undergoes a patented dehydration synthesis procedure. The final product results in a powder or liquid that can be effectively dosed either directly or mixed into a beverage. The primary factor for success is that the active ingredients are processed through the small intestine. This bypasses the long process of liver metabolization, allowing quick absorption by long-chain fatty acids into the lymphatics. In some instances, speed of efficacy can be improved fivefold, compared to standard oral drug delivery.

Just as important, DehydraTECH? can deliver results with lower levels of potential toxicity. Moreover, desired effects are felt much quicker (10 to 20 minutes versus 60 to 120 minutes), and dosages are more effectively absorbed into the bloodstream with minimal loss to therapeutic value. Lipids are used to provide gastric protection and rapid absorption of the medicine, and fatty acids are used in the synthesis process, allowing medications to be taken by patients without the bitter taste of the reformulated drug.

There are also case studies and ongoing market sales that support DehydraTECH? as having the best-in-class potential to disrupt an industry that is ripe for innovation. The technology has been developed in close collaboration with the National Research Council, the largest R&D organization in Canada. Through this partnership, the platform has been extensively evaluated through rigorous testing involving nuclear magnetic resonance, Fouier Transform Infrared Spectroscopy, Liquid Chromatography-High Resolution Mass Spectroscopy, Dynamic Light Scattering, and Zeta Potential Analysis.

The critical takeaway from these tests is that they have independently verified that DehydraTECH? does not create a new molecular entity. That means licensees with existing approval for market treatments can take an expedited regulatory path to market. It can also extend patent protection for billion-dollar franchise drugs that are nearing expiration.

A Platform with Endless Opportunity

Capitalizing on DehydraTECH ?’s potential to augment almost any existing orally administered treatment on the market, Lexaria has numerous applications for the platform under active development. One of the company’s most prioritized areas of research is using DehydraTECH? with antiviral treatments. The distinction that plays to the platform’s favor is that most existing antivirals on the market are fat-soluble and poorly absorbed by the body. Typically, that results in a need for a higher dose and cost, along with potentially severe side-effects. 

Nearly everyone is familiar with the dreaded needle-based delivery of certain medications or vaccinations – this is often because of poor bioavailability that often require injection to receive effective doses. This is expensive – requires a health care professional – and encounters significant patient resistance. All this could be a thing of the past with DehydraTECH.

Clinical studies conducted by Lexaria have proven that DehydraTECH? can significantly increase the bioavailability of fat-soluble drugs, meaning they can make efficient use of an active ingredient without the need for a patient to stack the doses. That distinction creates a wealth of opportunities. 

Lexaria is poised to begin testing its feasibility with different antiviral medications, with over 20 additional antiviral drug candidates identified for add-on indications. The technology demonstrates the potential to treat viruses, including influenza, HIV, HSV, and other common but debilitating ailments where limited treatment options are available. 

The results show that DehydraTECH? can be a perfect platform to combine with a potential COVID-19 vaccine. Although no treatments are available for the virus as of yet, DehydraTECH? may ultimately prove its ability to increase the efficacy of a fat-soluble antiviral at a lower dose, which would allow for more accessible and less expensive mass distribution once a treatment is formulated.

Nicotine Sector is A $900 Billion Market Opportunity

Another substantial market opportunity for Lexaria, which they are already exploiting, is for the DehydraTECH? platform’s ability to seize opportunities within the nicotine industry. Cigarettes continue to remain the number one cause of preventable deaths worldwide, with over 7 million deaths per year linked to related ailments. Contrary to popular belief, nicotine is not the primary cause of these diseases, rather it is the tar and chemicals released through the combustion and inhalation of tobacco smoke into the lungs. 

In the past few years, the FDA has addressed this problem by creating more burdensome regulations of cigarettes and encouraging the development of alternative nicotine sources that can deliver the chemical without any of the toxic by-products of burning tobacco. Oral delivery of nicotine is already on the market, with chewing gum being an example. In 2019, for the first time in its 90-year history, the FDA actually issued a “reduced-risk” notice for certain forms or orally delivered nicotine.

Lexaria is working to extend that option while simultaneously providing a means for a more efficient and safe level of absorption. Since 2019, the company secured a group license with Altria (NYSE: MO), one of the world’s largest tobacco companies, to develop an orally administered nicotine solution. The rapid absorption rate, high bioavailability, and palatable nature of DehydraTECH? treatments lends itself perfectly to this application and could provide a dynamic solution to both the physical and behavioral traits associated with nicotine addiction. Plus, the nicotine market may be in for rapid expansion.

Recent clinical evidence reveals that nicotine has a wide range of effects on the brain, potentially including some healing properties. Researchers are testing nicotine and related compounds as treatments for Alzheimer’s disease, Parkinson’s disease, attention-deficit/hyperactivity disorder (ADHD), and other conditions. Thus, with Lexaria already rooted in the sector, it can become a long-term asset as the compound is evaluated for additional large-market opportunities.

Pharmaceutical-Grade CBD Opportunities

Lexaria is further positioning the DehydraTECH? platform toward its use within the medicinal cannabis and CBD sector. The FDA has begun working with Congress to create more explicit rules for CBD dietary supplement commercialization in the United States. Those clarifications can open the doors to significant revenue-generating opportunities from both the recreational and pharmaceutical side of the sector.

Lexaria has secured eight commercial licensing deals with maturing brands in the cannabis sector, and early tests of the DehydraTECH? platform with these products have been extremely promising. In particular, the company is well-positioned to leverage its platform to the pharmaceutical side of the CBD market, potentially with companies conducting pharma-level R&D with cannabinoids, like GW Pharma (NasdaqGM: GWPH). 

From that perspective, DehydraTECH? can transform the way cannabinoids enter the bloodstream through the gastrointestinal tract. The rapid and effective bioavailability, combined with its innate flavor masking, provides for a much-improved product profile on several fronts. For example, the company conducted a case study with DehydraTECH?-powered TurboCBD 90mg capsules against a competitor’s 100mga generic CBD capsule of the same strength. They found that patients were able to have the same blood concentration of CBD at 30 minutes when using DehydraTECH? compared to the competitor generic dose that required 150 minutes to reach a similar level of concentration. And, compared to a competitor’s 100mg capsule despite being a 10mg lower dose than the competitor, patients using TurboCBD recorded higher levels of absorbed CBD throughout the entire test compared to the total absorption of the competitor’s 100mg capsule.

This study demonstrates the rapid absorption advantage of DehydraTECH? treatments compared to competing products. Lexaria is proving they can deliver higher levels of relief quicker than standard capsules or injections even when a lesser dosage is used. This is a characteristic seen in nearly every application in which DehydraTECH? has been studied so far and reinforces the idea that the platform could work to improve existing treatments almost universally. 

Keep in mind that GW Pharma’s lead product formulation of highly purified CBD, EPIDIOLEX® (cannabidiol), can be an example of a massive sector opportunity. That drug is marketed for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome in patients 2 years of age and older, two rare and particularly difficult to treat forms of epilepsy. The DEA has descheduled EPIDIOLEX®, which was launched in November 2018 and is now available by prescription only in the U.S. 

Critics of that drug point to side effects and taste as primary factors for not using the drug. Lexaria can help address both of those concerns.

Setting Up 2020 For Uplist And Market Penetration

Lexaria Bioscience is actively researching markets that could benefit most from their DehydraTECH? platform. COVID-19 has helped to allow fast-track designations for many treatment candidates to hopefully expedite the discovery of a vaccine. At the same time, it’s possible that the rapid and effective absorption offered by DehydraTECH? could substantially benefit the best vaccine candidates in that niche category.

Further, Lexaria has identified opportunities and is leveraging established relationships with multiple pharmaceutical, nicotine, and cannabis/CBD companies to create more effective treatments and revenue-generating opportunities in 2020. And, the company has alluded to additional potential partnerships planned throughout the remainder of this year. All can be significant value drivers moving into the back half of 2020.

Finally, the company has announced that a major US exchange uplist program is underway, which will likely help boost company exposure to additional investors. The technology being developed by this company offers nothing less than a comprehensive suite of advantages. With a near-infinite set of potential applications, investors should keep an eye on Lexaria as they continue on their mission to work with industry leaders in improving the standard of care for patients in a broad range of treatments

Also, with licensees already on the books, combined with the potential of near-term monetization of non-core assets, Lexaria Bioscience may be well-positioned to increase shareholder value in the coming months. Long-term prospects, though, are most appealing. And the company’s strength in that respect may be its most compelling feature. 

 

Disclaimer

This communication was produced by PCG Digital Holdings, LLC, and affiliate of PCG Advisory Inc., (together “PCG”). PCG is an integrated investor relations, communications and strategic advisory firm. The information contained on this may be ‘Paid Advertising’ for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the “Securities Act”). PCG may be compensated by respective clients for publicizing information relating to its client’s securities. For more information in terms of compensation received for services provided by PCG, see the pertinent advertising materials relating to the respective client. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy.

PCG is not a registered or licensed broker, dealer, broker-dealer, investment adviser nor investment manager, nor does PCG engage in any activities that would require such registrations. PCG does not provide investment advice, endorsement, analysis or recommendations with respect to any securities, and its services to or statements about its clients should never be construed as any endorsement of or opinion about any security of any client.  No information contained in this communication constitutes an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other similar product or service regardless of whether such security, product, or service is referenced in this communication. Further, nothing in this communication is intended to provide tax, legal, or investment advice and nothing in this communication should be construed as a recommendation to buy, sell or hold any investment or security or to engage in any investment strategy or transaction. For full disclaimers, including compensation received for professional services, please visit www.pcgadvisory.com/disclosures

Media Contact
Company Name: PCG Digital Holdings
Contact Person: Kenny Ellis
Email:Send Email
City: New York
State: New York
Country: United States
Website: https://pcgadvisory.com/

SANUWAVE Health Inc. Poised For Substantial Growth As Planned Acquisition Of Celularity's UltraMIST® Nears; Exclusive Partnership For Wound Care Biologics Targets A $10 Billion Market Opportunity

When it comes to finding value within emerging technologies, staying focused on the companies that fill a niche market opportunity can deliver substantial rewards. In the regenerative medicine products space, SANUWAVE Health (OTCMKTS: SNWV) may be such a company, showing that its strong portfolio of non-invasive, wound-healing assets may present a best-in-class alternative to competing products and treatments. 

SANUWAVE recently announced its intent to acquire Celularity’s UltraMIST® Ultrasound Healing Therapy asset as well as exclusive partnership rights for Celularity’s wound care biologic products., a deal that is expected to close in July of this year. The acquisition would create a leading provider of advanced wound care solutions that improves clinical outcomes across the continuum of care. It will make SANUWAVE substantially stronger in terms of revenue growth, product placement, and cash flow generation. Moreover, the enhanced portfolio of advanced wound care assets makes the near and long-term value-proposition attractive at current valuation levels. It uniquely positions SANUWAVE to leverage a larger combined sales force and cross-selling opportunities to capture revenue across the entire advanced wound care patient pathway from the initial stages of treatment to wound closure. 

SANUWAVE dermaPACE® System

SANUWAVE Health, Inc. is an emerging shockwave technology company focused on the development and commercialization of proprietary regenerative technology for the treatment of tissue, musculoskeletal, and vascular structures. Operating in the estimated $10.8 billion advanced wound care market, the company received FDA clearance for its flagship technology dermaPACE® in 2017 for the treatment of diabetic foot ulcers and began to commercialize the system in January 2019 after CMS granted SANUWAVE a reimbursement tracking code to allow billing for the procedure. Also, SANUWAVE currently has placed 130 dermaPACE® Systems in wound clinics the U.S. and over 450 including international markets. 

SANUWAVE’s dermaPACE® System is a non-invasive device for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures, and was developed to treat chronic wounds. With therapeutic sessions lasting only between 5 and 7 minutes, the system utilizes a proprietary form of high-energy, focused shockwave technology that activates biologic signaling and angiogenic responses, which promote rapid and effective healing. Extensive clinical studies have proven the device’s safety and efficacy in treating diabetic foot ulcers. Internationally the system can be utilized for the treatment of post-operative wound healing defects, post-traumatic wounds, deep-partial thickness burns, decubitus ulcers, arterial leg ulcers, and venous leg ulcers. These benefits are in sharp contrast to products from 3M Company (NYSE: MMM) and Johnson & Johnson (NYSE: JNJ) that only treat symptoms or provide antiseptic dressings to cover the wounds.

The benefits of the dermaPACE® system have helped SANUWAVE establish strong relationships with leading clinics and physicians, with over 300 clinicians certified to provide treatment with the platform. dermaPACE® is one of only a few platforms that offer a non-invasive, convenient, and safe procedure that can be easily combined with other modalities.

The company is taking its first transformative stride through the accretive acquisition of Celularity’s UltraMIST® and the exclusive license of the Celularity wound care biologic products, Biovance® and Interyl®, which are excellent complements to the dermaPACE® System. The UltraMIST® device is already established in over 900 wound care clinics and provides SANUWAVE with a strong reoccurring revenue stream from orders of the applicators for the device, which are disposable and provided in a case of twelve single-use (per patient).

The Celularity’s UltraMIST® Bring Accretive Value, Wound Care Sales Force, and Complementary Wound Care Technology

The addition of the Celularity wound care assets provides a platform of scale with approximately 900 customer accounts a 25-person team of wound care professionals, and an innovative energy transfer technology. The planned combination of UltraMIST® and the dermaPACE® System is expected to create a substantial opportunity to demonstrate improved patient outcomes over the current standard of care, initially for diabetic foot ulcers and across all wound indications in the future. 

Also creating competitive distance, this acquisition will provide SANUWAVE a comprehensive platform with the therapeutic power to treat the patient from beginning to end of the healing process, creating an effective all-in-one solution for patients while maximizing potential revenues for the company. And because of its practical and efficient treatment regimen, the end result of the combination may lead to a best-in-class position and serve as the standard of care to wounded patients with urgent need.

The value-driver in the deal with Celularity comes through its UltraMIST® system. This therapeutic device produces a low frequency, non-contact ultrasound energy that can cleanse wounds and promote healing through the removal of bacteria and inflammatory cells in the area. The UltraMIST® system is already approved in the U.S. for all acute and chronic wound indications and is currently used in hospitals, wound care centers, and nursing homes across the US. The technology is especially unique because the device never touches the wound surface, making the application pain-free. 

Noting the pain-free aspect, consider the comparison of UltraMIST® to the option of disinfectant scraping to treat wounds. Comparably, UltraMIST® is the gold standard. And considering that the device is FDA approved for treating painful diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds, this painless application may enjoy expedited market appreciation from patients who are already suffering from chronic wound conditions.

Exclusive Wound Care Biologics Partnership with Celularity

SANUWAVE will benefit from a second Celularity product that can further position SANUWAVE as a leading and comprehensive wound care platform provider. Biovance® is a second asset and is a flexible, human amniotic membrane allograft that provides a natural foundation for wound healing. The technology utilizes cells and proteins that serve as a functional extracellular matrix required to jumpstart the tissue regeneration and wound healing process. Not only is the treatment effective, but it is adaptable to many different sizes and types of wounds. Also, remarkable and an enormous product benefit is its ease of storage at room temperature for up to five years.

The third product coming from Celularity is Interfyl®, a human connective tissue matrix. Interfyl® is designed to replace damaged integumental soft tissue and augment inadequate connective tissues, as well as repair small surgical defects such as exposed tendons or nerves. Available in both flowable and particulate forms, the technology is designed to be adaptable to irregular wound shapes while still providing effective structural support. 

Not only is Interfyl® a strong complement to Biovance® and UltraMIST®, but it helps to set the stage for SANUWAVE to capitalize on multiple strategic and market opportunities. The complementary and comprehensive portfolio of treatment options places SANUWAVE in an excellent position to earn a significant share of the global wound care market and provide the best therapeutic option and care to patients in need.

Extending Revenue Opportunities From Start-To-Finish Capability

The most attractive part of the planned acquisition of UltraMIST® and the exclusive license of Biovance® and Interyl®, is that it can position SANUWAVE to provide start-to-finish wound-care treatment. This unique capability may play solely to SANUWAVE’s benefit, as few, if any, competitors have the resources to integrate multiple assets within its portfolio to provide a comprehensive treatment from wound discovery to closure. With access to dermaPACE®, UltraMIST®, Biovance®, Interfyl®, and WoundShield®, SANUWAVE can administer all five complementary therapies at different stages of the healing process to decrease bacteria, decrease inflammation, and increase perfusion. The ultimate result will lead to an overall better closure of the wound. 

Here’s another interesting note. Clinical trials have indicated that dermaPACE® alone can reduce the amputation rate caused by advanced diabetic foot ulcers by more than 2.5x compared to a control group. The treatment’s combination with UltraMIST® and other wound prepping technologies is expected to decrease the rate of amputation further and simultaneously provide patients with a painless and effective solution.

Moving forward, the synergistic mechanisms of action in the technologies developed by SANUWAVE and Celularity create a significant chance for upcoming clinical trials to demonstrate a dramatically improved patient response over the current standard of care. The integration of assets provides the ability to cross-sell dermaPACE® into existing business relationships with wound care facilities and hospitals. With UltraMIST® already being used to heal chronic wound patients, there is a leveraged opportunity to add the complementary dermaPACE® platform to many of these treatment regimes. 

The combination of the assets will undoubtedly contribute to the future scaling and globalization of the treatments as well. SANUWAVE has already noted that the cash-flow from UltraMIST® will help support the planned commercialization phases of dermaPACE®. They also highlighted that the synergies will provide financial benefits from cost savings in streamlining suppliers, marketing, and sales organizations. Additionally, capital expenditures to penetrate new markets is expected to be low, resulting in a free cash flow conversion of 95-98% from each new placement. The limited operating overhead will also enable SANUWAVE to quickly scale its platform as it gains more recognition as an effective, painless, and comprehensive wound care solution.

2020 Can Be Transformational

Building on an already strong foundation, SANUWAVE’s combined portfolio with Celularity assets provides multiple avenues for continued product and revenue growth. The complementary nature of SANUWAVE and Celularity’s wound care assets also broadens the addressable indications and expands the company footprint across multiple sectors. The global commercialization strategy of dermaPACE® and UltraMIST® will also benefit substantially from existing clinical relationships and a growing international market presence and the utilization of the newly combined sales force.

Importantly, to hit the ground running, no technological updates are required for these platforms to work with one another. And, the complementary nature of the therapeutic capabilities opens a natural sales channel for additional treatment indications. Thus, growth is inherent to the acquisition and can provide immediate expansion into other treatment markets. 

The underlying value opportunity driving investor interest in SANUWAVE is that its invigorated and comprehensive wound care solutions platform may ultimately earn its place as an industry-leading wound care treatment provider from discovery to closure. Moreover, they may be the only company able to make that claim. Also, with synergistic platforms that work with one another, the need for physicians and patients to use a combination of treatment modalities from different, unrelated companies throughout the healing process can be eliminated. This advantage should not go unnoticed, especially when inefficient treatment can lead to severe infection, amputation, or death.

Thus, there is comfort in knowing that patients and physicians alike can soon utilize clinically proven, start-to-finish wound care solutions that can provide better results and save lives. SANUWAVE should be credited for leading that change.

Disclaimers:

This article was prepared by Blue Hawk Media, LLC. Blue Hawk Media, LLC is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. The information made available by Blue Hawk Media, LLC is not intended to be, nor does it constitute, investment advice or recommendations. The contributors may buy and sell securities before and after any particular article, report and publication. In no event shall Blue Hawk Media, LLC be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or made available by Blue Hawk Media, LLC, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages.   Please refer to SANUWAVE's most recently filed 10-K or 10-Q and its website, as applicable, for the most current publicly available information. For complete disclosure, including compensation received, please click here. This content was syndicated by Soulstring Media Group, LLC.

Media Contact
Company Name: Blue Hawk Media, LLC
Contact Person: Jacob Ellison
Email:Send Email
Country: United States
Website: https://www.soulstringmedia.com

Surgical Equipment Market Growth Is Fueled By Rising Aged Population, Increasing Medical Processes and Modernization in Operating Devices Till 2025 | Million Insights

Surgical Equipment Market Growth Is Fueled By Rising Aged Population, Increasing Medical Processes and Modernization in Operating Devices Till 2025 | Million Insights
Million Insights - World's Fastest Growing Market Research Database
According to new report available with Million Insights, the global surgical instrument industry report on is foretold to provide a robust support for market players to lay a solid foundation for their business growth. It includes a comprehensive evaluation of the market's growth status and market risk.

Global Surgical Equipment/Instruments Market was valued at USD 10.5 billion in 2016 and is expected to reach a value of USD 20.3 billion by 2025. Global surgical equipment market is expected to experience brisk growth due to rise in demand for nominal hostile surgeries over the forecast period. Novel technologies such as robot and power assisted medical tools introduction in recent past is estimated to further enhance industry growth.

Surgical tools are medicinal devices that serve some specific need during any surgery. These devices allow the physical alteration of biological tissue to deliver access to internal body parts. This equipment’s are tools that are used to complete functions such as suturing cutting, holding, dissecting, retracting, or grasping. These instruments are hand handled or sometimes power based robotic devices. Technologies viz. robotic based medical devices and minimally invasive medical equipment development are presumed to be key driving factors for the surgical equipment market. Rise in aged population coupled with increase in medical processes is estimated to fuel the growth over the forecast period. Modernization in operating devices which provide improved & better outcomes along with increase in demand for less complicated procedures are some important success factors that are expected to contribute for the global growth over the six year period. Growth in adaptation and approval for arthroscopy and minimal invasive procedures usages due to convenience is expected to further complement the market growth.

Want To Access Full Research Report On Global Surgical Equipment Market? Click Here: https://www.millioninsights.com/industry-reports/surgical-equipment-market

Growth in demand for advanced twisted healing materials such as medical adhesives, glues, high-strength hemostats, fibrin, and other sealants used on daily basis for medical procedures are presumed to hinder the growth. Stringent government norms on power devices in certain regions are expected have negative impact on the market growth over the forecast period. Due to side effects related with some medical tools making people think twice before using the device. Several inadequate product quality assurance concerns to performance related to this device, improper procedures in sterilization for used equipment affect the individual health which is further expected to reduce the industry growth. Lack of affirmative governing structure in some developing regions is presumed to act as restraints for the market expansion across the globe. Huge price competition among the industry participants is presumed to hamper the Industry growth. Emerging economies such as India and China are presumed to be an opportunity for the industry participants to enter in this untapped market.

Based on product type surgical equipment market is segmented into surgical handheld instruments, staples & electrosurgical devices and surgical sutures. The surgical handheld instruments are further segmented as retractors, scalpels, and scissors and forceps. Till 2012, surgical staples and sutures appeared as maximum revenue generating product in surgical equipment market across the world. But, electrosurgical instruments are presumed to witness pleasing growth over the six years period owing to the rise in demand for minimally invasive operating procedures that greatly use this equipment.

The market is classified as Neurosurgery, Wound Closure, Plastic and reconstructive surgeries, Urology, Thoracic surgery, Cardiovascular, Obstetrics and gynaecology, Orthopaedic surgery, Micro vascular, Laparoscopy and Others based on different applications. Under developed regions such as North America and Europe are amongst the regional market for this equipment. And under the developing regions Asia Pacific are the regional markets catering the demand for this instrument. North America appeared as the maximum revenue contributing regional market due to constant R&D initiatives along with technological innovation which is leading to the better products development. Thus this is expected to boost the regional market growth. Asia Pacific is expected to grow at a lucrative CAGR over the next six years due to increasing awareness and adaptation pertaining to the advanced surgical equipment. Rise in disposable income is expected to propel the market growth. Rise in disposable income in emerging economies such as India is presumed to compliment the increase in demand for surgical equipment market in this region.

Many companies are implementing strategies such as collaboration acquisitions, and expansions to hold a strong position in this industry. Surgical equipment market is highly cost intensive with huge investment cost. Industry participants are investing heavily on research and development to have competitive advantage. Product innovation and product introduction is the important strategy adapted in this industry. Prominent industry participants includeKLS martin group, Smith & Nephew PLC, Zimmer holdings Inc., Ethicon Inc., Carefusion Corporation, Alcon Laboratories Inc., Conmed Corporation and Stryker Corporation. Stryker, Carefusion and Zimmer are observed to dominate the industry for electrosurgical instruments in recent past.

You Can Also Request Absolutely Free Sample Copy at: https://www.millioninsights.com/industry-reports/surgical-equipment-market/request-sample

Market Segment:

Surgical Equipment/Instruments Product Outlook (Revenue, USD Million; 2014 - 2025)
        ? Surgical Sutures and Staplers
        ? Handheld Surgical Devices
            ? Forceps and Spatulas
            ? Retractors
            ? Dilators
            ? Graspers
            ? Auxiliary Instruments
            ? Cutter Instruments
            ? Others
        ? Electrosurgical Devices

Surgical Equipment/Instruments Application Outlook (Revenue, USD Million; 2014 - 2025)
        ? Neurosurgery
        ? Plastic and Reconstructive Surgery
        ? Wound Closure
        ? Obstetrics and Gynecology
        ? Cardiovascular
        ? Orthopedic
        ? Others

Surgical Equipment/Instruments Regional Outlook (Revenue, USD Million; 2014 - 2025)
        ? North America
            ? U.S.
            ? Canada
        ? Europe
            ? Germany
            ? UK
        ? Asia Pacific
            ? China
            ? India
        ? Latin America
            ? Brazil
            ? Mexico
        ? MEA
            ? South Africa

Explore the Latest Press Releases available with Million Insights:

1. Car Rental Market - https://www.millioninsights.com/press-releases/car-rental-market

2. Predictive Analytics Market - https://www.millioninsights.com/press-releases/predictive-analytics-market

About Million Insights

Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive marketplace that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.

For More Information: www.millioninsights.com

Media Contact
Company Name: Million Insights
Contact Person: Ryan Manuel
Email:Send Email
Phone: 91-20-65300184
Address:Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar
City: Pune
State: Maharashtra
Country: India
Website: https://www.millioninsights.com/industry-reports/surgical-equipment-market

Global Non-Contact Temperature Market Report 2013-2028 by Top players - FLUKE, OMRON & Turck : Radiant Insights, Inc.

Global Non-Contact Temperature Market Report 2013-2028 by Top players - FLUKE, OMRON & Turck : Radiant Insights, Inc.
"Radiant Insights,Inc"
Radiant Insights, Inc has announced the addition of the "2013-2028 Report on Global Non-Contact Temperature Market by Player, Region, Type, Application and Sales Channel" report to their offering.

The global Non-Contact Temperature market was valued at $XX million in 2018, and analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global Non-Contact Temperature Market from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Non-Contact Temperature market.

Leading players of Non-Contact Temperature including:
? FLUKE
? Accurate Sensors
? OMRON
? IFM Electronic
? Turck
? Micro-Epsilon
? OMEGA
? LumaSense
? Calex Electronics
? Melexis
? Keyence
? OPTEX Group
? Pasco
? Process-Sensors
? Proxitron
? Banner
? HTM
? Eluox Automation
? Bodach

Market split by Type, can be divided into:
? Infrared Temperature Sensors
? Fiber Optic Temperature Sensors

Access Sample Report of this report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-non-contact-temperature-market/request-sample

Market split by Application, can be divided into:
? Electronic Industry
? Metallurgy Field
? Petrochemical
? General Industry(pharmacy, Automobile)
? Transportation

Market split by Sales Channel, can be divided into:
? Direct Channel
? Distribution Channel

Market segment by Region/Country including:
? North America (United States, Canada and Mexico)
? Europe (Germany, UK, France, Italy, Russia and Spain etc.)
? Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
? South America Brazil, Argentina, Colombia and Chile etc.)
? Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

View Full Report with TOC @ https://www.radiantinsights.com/research/2013-2028-report-on-global-non-contact-temperature-market

Table of Contents
Chapter 1 Non-Contact Temperature Market Overview
1.1 Non-Contact Temperature Definition
1.2 Global Non-Contact Temperature Market Size Status and Outlook (2013-2028)
1.3 Global Non-Contact Temperature Market Size Comparison by Region (2013-2028)
1.4 Global Non-Contact Temperature Market Size Comparison by Type (2013-2028)
1.5 Global Non-Contact Temperature Market Size Comparison by Application (2013-2028)
1.6 Global Non-Contact Temperature Market Size Comparison by Sales Channel (2013-2028)
1.7 Non-Contact Temperature Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)

Chapter 2 Non-Contact Temperature Market Segment Analysis by Player
2.1 Global Non-Contact Temperature Sales and Market Share by Player (2016-2018)
2.2 Global Non-Contact Temperature Revenue and Market Share by Player (2016-2018)
2.3 Global Non-Contact Temperature Average Price by Player (2016-2018)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player

Chapter 3 Non-Contact Temperature Market Segment Analysis by Type
3.1 Global Non-Contact Temperature Market by Type
3.1.1 Infrared Temperature Sensors
3.1.2 Fiber Optic Temperature Sensors
3.2 Global Non-Contact Temperature Sales and Market Share by Type (2013-2018)
3.3 Global Non-Contact Temperature Revenue and Market Share by Type (2013-2018)
3.4 Global Non-Contact Temperature Average Price by Type (2013-2018)
3.5 Leading Players of Non-Contact Temperature by Type in 2018
3.6 Conclusion of Segment by Type
Continued….

Browse report of similar category available with Radiant Insights, Inc.:
? Battery Charging IC Market - https://www.radiantinsights.com/research/global-battery-charging-ic-market-analysis
? Intelligent Electronic Devices Market - https://www.radiantinsights.com/research/2013-2028-report-on-global-intelligent-electronic-devices-market

About Radiant Insight
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist - USA
Email:Send Email
Phone: (415) 349-0054, Toll Free: 1-888-928-9744
Address:201 Spear Street 1100, Suite 3036
City: San Francisco
State: CA
Country: United States
Website: www.radiantinsights.com/research/2013-2028-report-on-global-non-contact-temperature-market

Christian Author Calls for Fresh Commitment to God’s Truth

Christian Author Calls for Fresh Commitment to God’s Truth
I didn't expect to finally discover a writing that completely exposes such a direct path to victory in Christ. This book caters to both the devoted life-long Christian and those who count today as the first day of their journey with Christ. Much of life is spent at war with the symptoms of a root cause. If you want to get to the bare root of what's been holding you back, this is the book for you. — Pastor David Jordan, NOW Church, Plainfield, IL.
Long time Christian worker and Kharis Publishing author, Denise White, writes that victory in Christ is not only possible but also attainable, if only Christian believers will commit afresh to discovering and following all of God's truth. Her book titled, Called to Truth - A Practical, Biblical Guide to Spiritual and Physical Wholeness, is now available in bookstores nationwide.

CHICAGO, Ill. - June 25, 2020 - Why do many Christians still feel lost or defeated, even though they go to Church and pray regularly? Is it possible to experience an ongoing sense of victory and joy in Christ? Christian worker and author of Called to Truth, Denise White, maintains that sustainable spiritual breakthrough is a possibility for every Christian, if there is a radical commitment to follow all of God’s truth.

New Mindset:

She wrote from her personal experience of failure and frustration and the journey that led her to discover God’s grace and peace. According to Denise, this journey to freedom begins with a new mindset, “Mercifully, God showed me how my way of thinking had led me into defeat and frustration. Trying to solve problems, with worldly knowledge, left me dismayed and discouraged. God’s word says “to be strong and courageous.” Why was I feeling so buried alive with despair? I had made mistakes because of my lack of knowledge and disobedience. I was buried alive with despair because there was a mountain in my life. At the time, I had no revelation of how God had given me tools of spiritual truths to move my mountain. The tools that I was using were the resources of the world and my efforts. The tools of the world were not moving my mountain but keeping me in bondage to those mountains. My journey to truth began when I surrendered my life and my way of thinking to His, and I wanted Him to show me the way to freedom.”

Commitment to all of God’s Revealed Truth:

Author noted that the next step after a renewed mindset is to seek and accept all of God’s truth as revealed in the Holy Scriptures. She cautioned Christians against a ‘pick and choose’ attitude towards the Word of God. Again, using her own example, she writes, “The more truth that was penetrating my being, the more I searched for answers and a deeper understanding. “For the Word of God is quick, and powerful, and sharper than any two-edged sword, piercing even to the dividing asunder of soul and spirit, and of the joints and marrow, and is a discerner of the thoughts and intents of the heart” (Hebrews 4:12). The truth of God reveals His amazing power. When His power is revealed to us, it frees us from bondage. Part of my search for truth began with Mark 16:15-20, John 14:12, and Revelation 10:11. I knew God’s word was true, so why was I not seeing evidence of Mark 16 in my life. According to Mark 16:15-20, those who believe are to cast out demons; speak in new tongues; remove Satan from their lives (take up serpents); anything we drink (receive into our soul) will not hurt us; and lay hands on the sick and they will recover. Additionally in John 14:12, Jesus said those who believe would do what He did, and we would do greater works when He ascended to go to the Father. Why was I not seeing this? What truth did I not yet know or understand? Where are the believers who have faith for these things? I wanted to be one of those that believe!! Revelation 10:11 says we are to overcome Satan in our own lives and have a testimony. I wanted my testimony. After asking, seeking, and knocking, spiritual truths were revealed to me.”

Spiritual Breakthrough:

As a Christian continues to follow all of God’s revealed truth, there will be real spiritual breakthrough, including a legitimate experience of God’s miraculous works in ones dailiness. Does it mean that there will no longer be challenges? Denise pushes hard against that notion, “After salvation, it is a lie if you think everything in your life will be easier. It is just the beginning of the good fight of faith. Life with Jesus Christ brings freedom, but it is a battle to keep Satan and the world from stealing that freedom. Once you have a personal revelation of God’s truth in your own life, your heart’s desire will be to help others know the same freedom. The Word of God never says the faith walk is easy, but the rewards are immeasurable which include eternal life. What does freedom through Jesus Christ mean to me? It means that I have accepted Jesus Christ as my LORD and Savior. It means I can talk to God any time, and I am never alone. It means the Holy Spirit is my Guide. He will lead me into living a life of obedience. It means I no longer agree with fear because it comes from Satan, the father of lies. It means I know that I am commanded by God to love myself, and I will not let Satan tell me otherwise. It means I fear God and want to please God, not man. It means that Jesus Christ defeated Satan. Through Jesus Christ, I am saved, healed, delivered, preserved, and made whole. It means the Word of God, God the Father, God the Son, and God the Holy Spirit are the only places that I will find complete and absolute truth. Truth is freedom!” In fact, the book is sprinkled with real examples of God’s miracle-working power in answer to prayers and in response to His mercy, not because there were no more challenges to the believer, but precisely because God is with us even in the midst of tough times, as we follow Him faithfully.

Denise White’s book, which was recently released by Kharis Publishing, an imprint of Kharis Media LLC, is now available wherever books are sold.

Available on Amazon: https://www.amazon.com/dp/1946277568

Book retailers and organizations are able to order directly through Ingram Content Group or from Author Clearance at: https://www.authorclearance.com/contact/

About Kharis Publishing:

Kharis Publishing, an imprint of Kharis Media LLC, is an independent book publisher focused on inspirational and faith-based books. Kharis’ dual mission is to give voice to underrepresented writers, and equip orphans in developing countries with literacy tools. That is why, for each book sold, the publisher channels some of the proceeds into providing books and computers for orphanages in developing countries, so these kids may learn to read, dream, and grow.

Learn more at: https://www.kharispublishing.com/

Media Contact
Company Name: Kharis Media LLC
Contact Person: Maribelle Martinez
Email:Send Email
Phone: 4795998657
City: Aurora - Chicago
State: IL
Country: United States
Website: https://www.kharispublishing.com

Automotive Lighting Market Hitting New Heights With Increasing Demand, Revenue Growth Analysis, Leading Key Players, Size, Segment And Evolution Rate Forecast To 2022 | Million Insights

Automotive Lighting Market Hitting New Heights With Increasing Demand, Revenue Growth Analysis, Leading Key Players, Size, Segment And Evolution Rate Forecast To 2022 | Million Insights
Million Insights - World's Fastest Growing Market Research Database
According To New Report Available With Million Insights, Global "Automotive Lighting Industry" Study Offers A Comprehensive Analysis Of The Business Models, Key Strategies, And Respective Market Shares Of Some Of The Most Prominent Players In This Landscape. The Report Begins With A Market Overview Capturing The Significant Facts Of The "Automotive Lighting Market".

The global Automotive Lighting Market size was valued at USD 19.64 billion in 2014 and is anticipated to reach USD 34.65 billion by 2022. Global automotive market will witness a steady growth with growing demand of automotive vehicle in the upcoming years. Increasing automotive production, rising concerns about vehicle safety, growing population and also government are driving the growth of the market. On addition to it, the increase in the purchasing power of the people is also creating opportunities for the market growth. Lighting is a vital component in automotive vehicles and plays a very important role in automotive safety. Automotive vehicle consists of variety of lights to increase the visibility in darkness and bad weather conditions and automotive lights also increase the conspicuity (that is the clarity of observing things) of the vehicle. The lighting system comprises of signalling and lighting devices. The lighting devices are placed in different locations of the vehicle including front, rear, top and interiors.

Halogen being an easily available and cost efficient technology has been majorly adopted by the market and is therefore, being used in lighting technology in the automotive sector also LED and Xenon are prominent lighting technologies which are in prime use in the global automotive lighting market. LED is likely to witness the highest growth amongst the three technologies during the forecast period. LED is relatively costlier, hence, at present is majorly being used in the high-end vehicles. However, research is being done to lower their cost as a result of which it would create significant rise in demand of LED lights in the upcoming years. The automotive lighting market is segmented based on technology, vehicle types, lighting applications, product sale and geography.

You Can Also Get Absolutely Free Sample Copy at: https://www.millioninsights.com/industry-reports/automotive-lighting-market-size/request-sample

On the basis of lighting applications, the market is segmented into rear lighting, front lighting, interior lighting and side lighting. The technology is segmented into LED, halogen and xenon. Based on vehicle type, the market is segmented into commercial vehicles and passenger vehicles. Based on product sale, the market is segmented in aftermarket product and OEM product. The geographical segmentation of automotive lighting include North America ( U.S. , Canada, Mexico) , Europe (Germany , UK , France , Italy) , Asia Pacific (China, India, Japan), RoW ( Brazil, Russia), Latin America and Middle East Africa. The global automotive lighting market is an excessively fragmented market with the presence of many regional and global local vendors. The global automotive lighting market is very dependent on automobile sales and the growth driven by the increase in automotive production. The market has seen constant innovations and development of new products, which in turn resulted in an excessive competitive environment for the manufacturers of the automotive lighting.

The key players of the global automotive lighting market include Ichikoh Industries Ltd., General Electric (GE), Koninklijke Philips N, Koito Manufacturing Co. Ltd, Magneti Marelli S.P.A, Valeo, Stanley Electric Co., Hella KGaA Hueck & Co., Ltd., Zizala Lichtsysteme GmbH, Osram GmbH, Hyundai Mobis, Royal Philips Electronics. The global automotive market is expected to grow at a CAGR 8% during the forecast period which can result to be profitable for the global automotive lighting market also. Ambient lighting is one application where lighting is strategically placed in the vehicle to create an experience and induce a psychologically pleasing effect. Headlamps, DRL, auxillary lights, off road lights, compact lights, dome lights, instrument display lights, fog lights and taillights are the popular segments in the global automotive lighting market attracting automotive designers with their unique and stylish looks. In the upcoming years the use of LED lighting is expected to cover of the total market soon in the upcoming years. Broadly automotive lighting market is segmented as Interior lighting and exterior lighting during the year 2015, the exterior lighting segment had dominated the global automotive lighting market, with a very high market share. Exterior lighting plays a very important role in ensuring safety and with more manufacturers focusing on the safety aspect demand for exterior lighting is expected to rise in the next seven years.

The growth in the Asia Pacific region is driven by India and China, which are the largest markets for automotive production in the Asia Pacific region. The Asia Pacific region is a hub for automotive components due to improved infrastructure, preferences and changing lifestyles, government initiatives, and overall reduction in vehicle production costs. There is a high growth in the number of vehicles in the BRIC nations which further creates large opportunity for the growth of automotive lighting market during the forecast period. Purchasing power is increasing which in turn is increasing the demand for advanced and sophisticated technologies which include advance front light system (AFS) and daylight running lights system (DRL). Automotive lighting indicates vehicle's presence, position, size, driver’s intentions regarding direction, and direction to travel and speed of the vehicle that is travelling. The demand for aesthetic lighting is also increasing which in turn would support the demand of lights in commercial and private cars.

Want To Access Full Research Report On Global Automotive Lighting Market? Click Here: https://www.millioninsights.com/industry-reports/automotive-lighting-market-size

Market Segmentation

Automotive Lighting Technology Outlook (Revenue, USD Million, 2012 - 2022)
    ? Halogen
    ? Xenon
    ? LED

Automotive Lighting Application Outlook (Revenue, USD Million, 2012 - 2022)
    ? Front/headlamps
    ? Rear
    ? Side
    ? Interior

Automotive Lighting Regional Outlook (Revenue, USD Million, 2012 - 2022)
    ? North America
    ? Europe
    ? Asia Pacific
    ? RoW

Read the Latest Press Releases available with Million Insights:

1. Motion Sensor Market – https://www.millioninsights.com/press-releases/motion-sensor-market                  

2. Middle East MCCB Market - https://www.millioninsights.com/press-releases/middle-east-molded-case-circuit-breakers-mccb-market                 

About Million Insights

Million Insights, is a distributor of market research reports, published by premium publish ers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.

For More Information: www.millioninsights.com

Media Contact
Company Name: Million Insights
Contact Person: Ryan Manuel
Email:Send Email
Phone: 91-20-65300184
Address:Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar
City: Pune
State: Maharashtra
Country: India
Website: https://www.millioninsights.com/industry-reports/automotive-lighting-market-size

FreeCast’s SelectTV Picks Up Entertainment Channels AMGTV and Take A Look

Our selling point has always been that our service is the only one that can give you everything. For a long time, that meant helping consumers find content, like a search engine. Now, we're working with content providers like Access Media to bring it directly to them.
A new agreement with Access Media puts two popular new channels on FreeCast's SmartGuide.

FreeCast and Access Media are announcing a partnership that will add two channels to FreeCast’s SelectTV and other SmartGuide-powered web television services. Access Media Group’s AMGTV and Take A Look will now join the FreeCast channel lineup and be made available to millions of customers.

AMGTV is a variety channel that already reaches over 60 million households via broadcast, cable and satellite, and OTT distribution. Take A Look is an entertainment network focusing on upcoming movies, popular television shows, and all the latest from Hollywood.

Both channels come to FreeCast’s SmartGuide at a time when the company is working to more tightly integrate content from external providers into the service by working more closely with its content partners than ever before. Rather than simply linking to existing streams of content, FreeCast is now creating both a more seamless experience for its own customers, and more robust revenue opportunities for its partners via Dynamic Ad-Insertion technology. 

FreeCast CEO William Mobley talked about the new channels and the shift in strategy: “These are great channels for us. Our selling point has always been that our service is the only one that can give you everything. For a long time, that meant helping consumers find content, like a search engine. Now, we’re working with content providers like Access Media to bring it directly to them. Many of our customers are media buffs with multiple streaming services and bigger entertainment budgets, so AMGTV and Take A Look are well-matched to that audience.”

Media Contact
Company Name: FreeCast Inc.
Contact Person: Tyler Shears
Email:Send Email
Phone: (407) 374-1607
Address:6901 TPC DriveSuite 200
City: Orlando
State: Florida
Country: United States
Website: https://freecast.com

Biophotonics Market To Grow With An Impressive CAGR By 2024 | Global Industry Size, Share, Top Key Players, Latest Coverage, Analysis of Geography Trends And Forecasts | Million Insights

Biophotonics Market To Grow With An Impressive CAGR By 2024 | Global Industry Size, Share, Top Key Players, Latest Coverage, Analysis of Geography Trends And Forecasts | Million Insights
Million Insights - World's Fastest Growing Market Research Database
According To New Report Available With Million Insights, Global "Biophotonics Industry" Size Research Report, Identifies New Revenue Opportunity In Biotechnology Segments. Biophotonics Market Trend Influencing Consumer Preferences, Global Industry Analysis And Opportunity Assessment Till 2024.

The global Biophotonics Market was valued at USD 34.29 billion in 2015 and is expected to reach USD 91.31 billion by 2024. The growth is primarily attributed to the advancements in nanotechnology, increasing the sophistication of medical devices and healthy demand for point-of-care treatment solutions.  Biophotonics involves the use of light energy to detect measure and manipulate the biological materials or activities. The growing sophistication of medical research is expected to fuel further studies in this field, thereby providing avenues for market growth. Besides research, biophotonics finds application in the biotechnology, defense, therapeutic, diagnostic and agriculture sector.

In-vitro diagnostic and medical imaging is expected to be the core application areas for biophotonics. However, the increased government support for innovative and affordable therapy may provide wider application scope and is expected to impact the market growth positively. Biophotonics is anticipated to witness high penetration in point-of-care devices, owing to the potential of minute observations which may offer targeted therapy options without causing any side effects. The advancements in the biosensors coupled with rapid applications of light therapy and microscopy are also expected to contribute towards industry growth.

Get Sample PDF and read more details about the "Biophotonics Market" Report 2024.   

Biophotonics techniques are rapidly deployed in agriculture applications for testing the crops. Microfluidics and monitoring techniques are expected to dominate the agriculture sector, owing to advancements in food surveillance and testing procedures. Genetically modified crops may also provide growth opportunities due to applications of this technology in biotechnology laboratories and research centers. Besides agriculture, the defense sector is also expected to provide growth opportunities owing to the emergence of chemical and biological warfare.

The market is segmented, by the application into spectro molecular, surface imaging, biosensors, see-through imaging, light therapy and microscopy. The see-through imaging sector is expected to command the highest share owing to the healthy demand for non-invasive treatment and applications in brain imaging.  On the basis on end-use, the market is segmented into medical therapeutics and diagnostics, its related test components and non-medical applications. Although the medical sector accounts for the ongoing industry growth, future growth may be due to the increased use in the non-medical fields such as agriculture and defense. Environment monitoring applications may also propel the market demand over the next eight years.

North America biophotonics market accounted for a sizeable share in 2015 owing to sound investment in R&D and the healthcare industry. Asia Pacific market is expected to witness significant growth due to rising geriatric population. Companies may eye developing countries such as Thailand and India, which are increasing their expenditure on healthcare facilities and R&D.

Technological advancements in imaging techniques are poised to keep research active. Imaging solutions such as 3D volumetric mapping are emerging as the key research areas providing an upsurge in uptake. However, owing to the nascent nature of such technologies, the applications are limited. Active collaboration of computer engineers and biologists is expected to help overcome challenges, eventually leading to industry growth. Further, y the ongoing research in nanotechnology is anticipated to provide growth opportunities.

The industry supply chain includes biologists and imaging solutions providers, which may integrate research to develop new products. The industry may face fierce competition leading to utilization of biophotonic devices at home. It may incentivize companies to develop competencies either by research or merger & acquisitions. Precision Photonics’ acquisition by Idex Corporation is one such example, leading to the development of in-house manufacturing capabilities for Idex. The healthy growth potential may incentivize firms to enter the industry. However, with only a handful key player with hefty investments, there is a potential barrier to new entrants.

Key players in the sector include AdvanDx, Affymetrix, Andor, Carl Zeiss, FEI Company, Hamamatsu Photonics, Lumenis, Olympus Corporation and Zecotek Photonics. The industry exhibits significant dominance of the US-based firms Affymetrix, which is established player in the healthcare instrument sector and FEI Company, which is into microscopy and imaging solutions.

Full Research Report on Global Biophotonics Market Analysis available at: https://www.millioninsights.com/industry-reports/biophotonics-market

Market Segment:

Biophotonics End-Use Outlook (Revenue, USD Billion; 2013 - 2024)
        ? Tests and components
        ? Medical therapeutics
        ? Medical diagnostics
        ? Non-medical application

Biophotonics Application Outlook (Revenue, USD Billion; 2013 - 2024)
        ? See-Through Imaging
        ? Microscopy
        ? Inside Imaging
        ? Spectro Molecular
        ? Other Analytics Sensing
        ? Light Therapy
        ? Surface Imaging
        ? Biosensors

Biophotonics Regional Outlook (Revenue, USD Billion; 2013 - 2024)
        ? North America
        ? Europe
        ? Asia Pacific
        ? RoW

Read the Latest Press Releases available with Million Insights:

1. Packaged Milkshakes Market – https://www.millioninsights.com/press-releases/packaged-milkshakes-market

2. Residential Washing Machine Market - https://www.millioninsights.com/press-releases/residential-washing-machine-market  

About Million Insights

Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.

For More Information: www.millioninsights.com

Media Contact
Company Name: Million Insights
Contact Person: Ryan Manuel
Email:Send Email
Phone: 91-20-65300184
Address:Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar
City: Pune
State: Maharashtra
Country: India
Website: https://www.millioninsights.com/industry-reports/biophotonics-market